Q3 2017

Filed May 12, 2017 · 10-Q · 42 days after period end · 0001213900-17-005082

Q3 2017 · 10-Q

Revenue—

Net Income

-$1.87M

N/M vs Q3 2016

EPS Diluted

$0.18

+80.0% vs Q3 2016

Operating Cash Flowderived-$1,507,500N/M

Same quarter

Metric	Q3 2017	Q3 2016	Q3 2015	Q3 2012
Revenue	—	—	—	$0.00
Net Income	-$1.87M	-$1.14M	$437.58K	-$427.83K
EPS Diluted	$0.18	$0.10	$0.04	-$0.03

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

TuHURA Biosciences, Inc. · CIK 1498382 · Engraved from SEC EDGAR